Slate Path Capital »

Newamsterdam Pharma Co Nv shares owned by Slate Path Capital

Quarter-by-quarter ownership of Newamsterdam Pharma Co Nv (NAMS) shares owned by Slate Path Capital from 13F filings

Historical chart of Slate Path Capital investment in Newamsterdam Pharma Co Nv

Tip: Access up to 7 years of quarterly data

All positions including Newamsterdam Pharma Co Nv held by Slate Path Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Newamsterdam Pharma Co Nv by Slate Path Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $9.1M 319k 28.44
2025-06-30 $5.8M 319k 18.11
2025-03-31 $6.5M 319k 20.47
2024-12-31 $8.2M 319k 25.70

More positions owned by Slate Path Capital

Hewlett Packard Enterprise (HPE)
Unity Software (U)
Union Pacific Corporation (UNP)
EQT Corporation (EQT)
Sandisk Corp (SNDK)
Amrize SHS (AMRZ)
Rocket Cos Com Cl A (RKT)
Cleveland-cliffs (CLF)
Warner Bros Discovery Com Ser A (WBD)
Nucor Corporation (NUE)
Nokia Corp Sponsored Adr (NOK)
Arrowhead Pharmaceuticals (ARWR)
Chesapeake Energy Corp (EXE)
Western Digital (WDC)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)

View all positions for Slate Path Capital

Top funds holding Newamsterdam Pharma Co Nv

Frazier Life Sciences Management
Bain Capital Life Sciences Investors
RA Capital Management
Capital World Investors
Fcpm Iii Services B.v.
Viking Global Investors
FMR
Deerfield Management Company
Jennison Associates
Wellington Management Company
Polar Capital Holdings
Medicxi Ventures Management
Adage Capital Partners GP
Cormorant Asset Management
Alliancebernstein

View all funds holding Newamsterdam Pharma Co Nv